FDA Issues Recall Statement On All Zantac (Ranitidine) Products
FDA NEWS RELEASE FDA Requests Removal of All Ranitidine Products (Zantac) from the Market FDA Advises Consumers, Patients and Health Care Professionals After New FDA Studies Show Risk The US Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac) The agency has determined that the impurity in some...